RAC1 and diabetes mellitus: Inhibition of NET formation or enhancement of the PI3K/Rac1 signaling pathway can ameliorate the impaired efferocytosis and reduce the enlarged ACs area in diabetic mouse wounds, emphasizing the potential of targeting NETs and macrophage signaling as therapeutic strategies to improve wound resolution in diabetes.